Posted in | News | Graphene | Nanobusiness

American Graphite Provides Update on Graphene Paper Project with CTI Nanotechnologies

American Graphite Technologies Inc. ("AGIN" or the "Company") is pleased to issue a corporate update in regard to its project with CTI Nanotechnologies LLC ("CTI") CTI reports that it has situated the majority of its equipment at the new R&D/manufacturing facility in Rockingham, Vermont.

The facility is currently being readied for the setup of the production line. CTI expects the line to be ready to start testing within 90 days.

CTI has advised that further testing of the graphene paper technology is proceeding well and they hope to have further updates on scalability shortly.

About the American Graphite Technologies Inc. and CTI Technologies LLC Agreement

On January 25th 2013, the Company announced it has entered into a strategic partnership with a private US company CTI Nanotechnologies LLC. ("CTI") to further the development and commercialization of Graphene Paper. American Graphite has provided its initial funding as laid out in the agreement with CTI and will provide updates as they occur. CTI is working on the development and commercialization of Graphene Paper. The initial funding received by CTI from the Company will be used to acquire test and manufacturing equipment to enhance CTI's existing facility located in Vermont with the goal of developing a prototype production machine that makes Graphene Paper in larger and more affordable sizes than currently available.

For more information visit the website at www.americangraphitetech.com

Source: http://americangraphitetechnologies.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.